RSM logo
Experimental Biology and Medicine

Home Current issue Browse archive Alerts About the journal Feedback
 
Exp. Biol. Med. 2007;232:323-335
© 2007 Society for Experimental Biology and Medicine

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brewer, G. J.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ORIGINAL RESEARCH ARTICLE

Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer’s Disease

George J. Brewer1

Department of Human Genetics, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan

1 5024 Kresge Bldg. II, Ann Arbor, MI 48109-0534. E-mail: brewergj{at}umich.edu

In this review, we point out that natural selection does not act to lessen human diseases after the reproductive and caregiving period and that normal levels of iron and copper that may be healthy during the reproductive years appear to be contributing to diseases of aging and possibly the aging process itself. It is clear that oxidant damage contributes to many of the diseases of aging, such as atherosclerosis, Alzheimer’s disease, Parkinson’s diseases, diabetes, diseases of inflammation, diseases of fibrosis, diseases of autoimmunity, and so on. It is equally clear that both iron and copper can contribute to excess production of damaging reactive oxygen species through Fenton chemistry. Here, we examine the evidence that "normal" levels of iron and copper contribute to various diseases of aging.

Keywords: iron, copper, atherosclerosis, Alzheimer’s disease

The investigations in our laboratory have been supported in part by Attenuon LLC, San Diego, California, and Pipex Therapeutics, Inc., Ann Arbor, Michigan, who are developing tetrathiomolybdate for various uses. Dr. Brewer has equity in, and is a paid consultant, for both companies.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Vasc MedHome page
R. N Easter, Qilin Chan, B. Lai, E. L Ritman, J. A Caruso, and Zhenyu Qin
Vascular metallomics: Copper in the vasculature
Vascular Medicine, February 1, 2010; 15(1): 61 - 69.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. A. Muller and L. W Klomp
Novel perspectives in mammalian copper metabolism through the use of genome-wide approaches
Am. J. Clinical Nutrition, September 1, 2008; 88(3): 821S - 825S.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
J. l. Sullivan
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Exp Biol Med, September 1, 2007; 232(8): 1014 - 1020.
[Abstract] [Full Text] [PDF]